首页> 美国卫生研究院文献>Oncotarget >Preoperative chemoradiotherapy creates an opportunity to perform sphincter preserving resection for low-lying locally advanced rectal cancer based on an oncologic outcome study
【2h】

Preoperative chemoradiotherapy creates an opportunity to perform sphincter preserving resection for low-lying locally advanced rectal cancer based on an oncologic outcome study

机译:根据肿瘤学结果研究术前放化疗可为低位局部晚期直肠癌的保留括约肌切除术创造机会

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Low-lying locally advanced rectal cancer (LARC) after preoperative chemoradiotherapy (CRT) can be surgically removed by either abdominperineal resection (APR) or sphincter preserving resection (SPR). This retrospective cohort study of 251 consecutive patients with low lying LARC who underwent CRT followed by radical surgery in a single institute, between March 2003 and November 2012, aimed to compare the oncological benefits between the two groups. 3-year disease free survival (DFS), overall survival (OS), cumulative incidence of recurrence and postoperative complications were compared between the two approaches. With median follow-up of 48.6 months, SPR group had higher 3-year DFS rate (86.4% vs 73.6%, P=0.023) and lower incidence of distant recurrence (12.0% vs 23.7%, P=0.026). The postoperative complications, incidence of local recurrence and the 3-year OS were comparable between the two groups. Pathologic T and N stage were the independent predictors for 3-year DFS (P=0.020 and P<0.001). In conclusion, our study suggest that low-lying LARC patients with a significant response to preoperative CRT can benefit from the advantage of SPR in preserving the anal sphincter function without compromising their oncologic outcome.
机译:术前放化疗(CRT)后低洼的局部晚期直肠癌(LARC)可通过腹腔会阴切除术(APR)或保留括约肌切除术(SPR)进行手术切除。这项回顾性队列研究于2003年3月至2012年11月间在一家机构中连续对251例低位LARC患者进行了CRT并接受了根治性手术,旨在比较两组患者的肿瘤学获益。比较这两种方法的3年无病生存期(DFS),总生存期(OS),复发累积发生率和术后并发症。中位随访48.6个月,SPR组3年DFS率较高(86.4%vs 73.6%,P = 0.023),远处复发率较低(12.0%vs 23.7%,P = 0.026)。两组的术后并发症,局部复发发生率和3年OS相当。病理T和N分期是3年DFS的独立预测因子(P = 0.020和P <0.001)。总之,我们的研究表明,对术前CRT有显着反应的低洼LARC患者可以受益于SPR的优势,可以保留肛门括约肌功能而不损害其肿瘤学结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号